Showing results (331-340 of 345) with videos related to
Sort By:
Pageof 35
Orphanet Journal of Rare Diseases|September 17, 2013
ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in vivo and in vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11β-hydroxylaseJohannes Hofland, Leo J Hofland, Peter M van Koetsveld, et al.Anaesthesia|March 21, 2017
Long-term outcomes and cost effectiveness of high-dose dexamethasone for cardiac surgery: a randomised trialJ M Dieleman, G A de Wit, A P Nierich, et al.Endocrine-Related Cancer|July 16, 2020
The IGF2 methylation score for adrenocortical cancer: an ENSAT validation studyS G Creemers, R A Feelders, N Valdes, et al.Pituitary|December 11, 2012
Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's diseaseR van der Pas, C de Bruin, A M Pereira, et al.Endocrine-Related Cancer|October 5, 2007
DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patientsY M H Jonkers, S M H Claessen, A Perren, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 28, 2023
Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA)S C Ebbers, M W Barentsz, D M V de Vries-Huizing, et al.Plos One|August 12, 2014
Somatostatin analogues for receptor targeted photodynamic therapySlávka Kaščáková, Leo J Hofland, Henriette S De Bruijn, et al.European Journal of Endocrinology|October 30, 2013
Cushing's disease and hypertension: in vivo and in vitro study of the role of the renin-angiotensin-aldosterone system and effects of medical therapyR van der Pas, J H M van Esch, C de Bruin, et al.Endocrine-Related Cancer|June 22, 2014
Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paragangliaThomas G Papathomas, Lindsey Oudijk, Ellen C Zwarthoff, et al.The Journal of Clinical Endocrinology and Metabolism|January 27, 2012
The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapyR van der Pas, C de Bruin, F W G Leebeek, et al.Pageof 35